9.	Stock Options and Stock-Based Compensation

The following is a summary of activity in the Company’s stock option plan for the nine months ended October 29, 2016:

 

		Number of Shares				Weighted- Average Exercise Price				Weighted- Average Remaining Contractual Term (Years)
Outstanding as of January 30, 2016			3,710,022			$	9.43
Options granted			1,426,700			$	1.26
Options exercised			—
Options forfeited			(1,053,535	)		$	9.02
Options expired			(773,325	)		$	9.92
Outstanding as of October 29, 2016			3,309,862			$	5.92				4.7
Options vested and expected to vest as of October 29, 2016			3,054,488			$	6.10				4.6
Exercisable as of October 29, 2016			1,479,669			$	8.36				3.4

The weighted average grant date fair value of options granted during the nine months ended October 29, 2016 and October 31, 2015 was $0.33 and $0.51, respectively.

During the three and nine months ended October 29, 2016 and October 31, 2015, the Company recorded stock-based compensation expense (benefit) and additional paid-in capital relating to stock-based compensation of approximately $(0.0) million, $0.1 million, $(0.0) million and $(0.5) million, respectively. During the three and nine months ended October 29, 2016, the Company recorded reversals of stock option expense of $0.0 million and $0.2 million, respectively, associated with the forfeitures of stock options, including $0.0 million and $0.1 million, respectively, for former executive officers. Stock-based compensation benefit is recorded in “Selling, general and administrative” expenses in the accompanying Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss.